Results 161 to 170 of about 2,986,989 (300)

IMPLEMENTASI KRIPTOGRAFI ELGAMAL DAN STEGANOGRAFI KOMBINASI LEAST SIGNIFICANT BIT DAN BLUM BLUM SHUB UNTUK PENGAMANAN PESAN RAHASIA DALAM GAMBAR [PDF]

Tujuan penelitian ini adalah untuk mengembangkan sistem keamanan data yang mengintegrasikan kriptografi ElGamal dengan steganografi Least Significant Bit (LSB) dan algoritma Blum Blum Shub (BBS).
Maulana Firman Nurdiansyah, -
core  

Isotretinoin and serum thyroid parameters: systematic review and meta-analysis. [PDF]

An Bras Dermatol
Mostafa N, Hong E, Stewart T.
europepmc   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Olopatadine plus mometasone for seasonal allergic rhinitis treatment: A pooled analysis of clinical trials. [PDF]

Braz J Otorhinolaryngol
Nakanishi M, Carbone LFB, Aggarwal V, Gordonsmith RH, Wu W, Barkate H, Anselmo-Lima WT.   +6 more
europepmc   +1 more source

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma‐cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

Molecular Oncology, EarlyView.
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou, Athina Markou, Eleonora Nicolo, Mara S Serafini, Qiang Zhang, Youbin Zhang, Lorenzo Gerratana, Andrew A. Davis, Huiping Liu, William J Gradishar, Carolina Reduzzi, Massimo Cristofanilli, Evi Lianidou   +12 more
wiley   +1 more source

Interpreting the effects of DNA polymerase variants at the structural level

Molecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi, Karolina Krzesińska, Ludovica Beltrame, Pablo Sánchez‐Izquierdo Besora, Matteo Tiberti, Mef Nilbert, Anna Rohlin, Elena Papaleo   +7 more
wiley   +1 more source

Evaluation of Biopolyurethane/Barley Straw-Based Engineered Wood Composites. [PDF]

Polymers (Basel)
Vėjelis S, Aglinskaitė UK, Kremensas A, Vaitkus S, Šeputytė-Jucikė J, Rimkienė A.   +5 more
europepmc   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

Medication Management Strategies at Hospital Admission: A Systematic Review and Meta-Analysis. [PDF]

Clin Transl Sci
Emadi T, Yiu CH, Liu S, Tang D, Yeung K, Baysari M, Budgeon C, Carter S, Criddle D, Fleming C, Francis M, Grover C, Hawthorne A, Hawthorne D, Khlentzos A, Khlentzos J, Krogh L, McMillan F, Moles R, Nguyen K, Oldfield L, Packer A, Penm M, Pham L, Phillips K, Poon S, Ratnanayagam G, Rigby D, Sanfilippo F, Shakib S, Tan E, Van Dort B, Yates P, Yik J, Angley M, Elliott RA, Penm J.   +36 more
europepmc   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

Molecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel, Izabela Kubiak, Lena Rutkowska, Żaneta Kasprzyk, Łukasz Kępczyński, Michał Bednarek, Dariusz Sobieraj, Jacek Wilkosz, Piotr Kania, Adam Jędrzejczyk, Bogdan Kałużewski, Agnieszka Gach, Tadeusz Kałużewski   +12 more
wiley   +1 more source